Jonathan P Segal1,2, Stephanie X Poo3, Simon D McLaughlin4, Omar D Faiz1,2, Susan K Clark1,2, Ailsa L Hart1,2. 1. St Mark's Hospital, Harrow, UK. 2. Department of Surgery and Cancer, Imperial College, London, UK. 3. Imperial Healthcare NHS Trust, London, UK. 4. Department of Gastroenterology, The Royal Bournemouth and Christchurch Hospitals, Bournemouth, UK.
Abstract
OBJECTIVE: Restorative proctolectomy is considered the procedure of choice in patients with ulcerative colitis who have failed medical therapy. Chronic pouchitis occurs in 10%-15% of patients, which often require long-term antibiotics to alleviate symptoms. Safety and efficacy of long-term maintenance antibiotics for chronic pouchitis has yet to be established. We aimed to assess the long-term safety and efficacy of maintenance antibiotic therapy for chronic pouchitis. DESIGN: This was an observational study. We followed up patients who were diagnosed with chronic antibiotic-dependent pouchitis. SETTING: Data were collected from our single specialist pouch centre. PATIENTS: Patients with chronic antibiotic-dependent pouchitis who had been maintained on antibiotics continuously for at least 1 year with a least one follow-up visit. MAIN OUTCOME MEASURE: Development of pouch failure defined by the need for an ileostomy, patient-reported side effects of antibiotics and development of antibiotic resistance found on stool coliform testing. RESULTS: Long-term use of antibiotics achieve remission in 21% of patients over a median follow-up of 102 (range 9-125). Pouch failure in association with chronic pouchitis after a median follow-up of 8.5 years occurred in 18%. Side effects of long-term antibiotic use occurred in 28% of patients, with resistance to antibiotics from at least one stool sample occurring in 78% patients. CONCLUSIONS: Although the use of antibiotics in chronic pouchitis may be justified, the use of long-term antibiotics must be weighed against potential complications associated with pouchitis and antibiotics.
OBJECTIVE: Restorative proctolectomy is considered the procedure of choice in patients with ulcerative colitis who have failed medical therapy. Chronic pouchitis occurs in 10%-15% of patients, which often require long-term antibiotics to alleviate symptoms. Safety and efficacy of long-term maintenance antibiotics for chronic pouchitis has yet to be established. We aimed to assess the long-term safety and efficacy of maintenance antibiotic therapy for chronic pouchitis. DESIGN: This was an observational study. We followed up patients who were diagnosed with chronic antibiotic-dependent pouchitis. SETTING: Data were collected from our single specialist pouch centre. PATIENTS: Patients with chronic antibiotic-dependent pouchitis who had been maintained on antibiotics continuously for at least 1 year with a least one follow-up visit. MAIN OUTCOME MEASURE: Development of pouch failure defined by the need for an ileostomy, patient-reported side effects of antibiotics and development of antibiotic resistance found on stool coliform testing. RESULTS: Long-term use of antibiotics achieve remission in 21% of patients over a median follow-up of 102 (range 9-125). Pouch failure in association with chronic pouchitis after a median follow-up of 8.5 years occurred in 18%. Side effects of long-term antibiotic use occurred in 28% of patients, with resistance to antibiotics from at least one stool sample occurring in 78% patients. CONCLUSIONS: Although the use of antibiotics in chronic pouchitis may be justified, the use of long-term antibiotics must be weighed against potential complications associated with pouchitis and antibiotics.
Authors: B Shen; J P Achkar; B A Lashner; A H Ormsby; F H Remzi; A Brzezinski; C L Bevins; M L Bambrick; D L Seidner; V W Fazio Journal: Inflamm Bowel Dis Date: 2001-11 Impact factor: 5.325
Authors: P Gionchetti; F Rizzello; A Venturi; F Ugolini; M Rossi; P Brigidi; R Johansson; A Ferrieri; G Poggioli; M Campieri Journal: Aliment Pharmacol Ther Date: 1999-06 Impact factor: 8.171
Authors: P Gionchetti; F Rizzello; G Poggioli; F Pierangeli; S Laureti; C Morselli; R Tambasco; C Calabrese; M Campieri Journal: Aliment Pharmacol Ther Date: 2007-05-15 Impact factor: 8.171
Authors: Simon D McLaughlin; Susan K Clark; Suja Shafi; Liljana Petrovska; Liljana Petrovksa; Paris P Tekkis; Paul J Ciclitira; R John Nicholls Journal: Clin Gastroenterol Hepatol Date: 2009-05 Impact factor: 11.382
Authors: G Pellino; D S Keller; G M Sampietro; M Carvello; V Celentano; C Coco; F Colombo; A Geccherle; G Luglio; M Rottoli; M Scarpa; G Sciaudone; G Sica; L Sofo; R Zinicola; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi Journal: Tech Coloproctol Date: 2020-03-02 Impact factor: 3.781
Authors: Gaurav Syal; Miles P Sparrow; Fernando Velayos; Adam S Cheifetz; Shane Devlin; Peter M Irving; Gilaad G Kaplan; Laura E Raffals; Thomas Ullman; Krisztina B Gecse; Phillip R Fleshner; Amy L Lightner; Corey A Siegel; Gil Y Melmed Journal: Dig Dis Sci Date: 2022-01-10 Impact factor: 3.487